Kishimoto, T., Kojima, Y., & Fujimoto, N. (2021). Significance of secretory leukocyte peptidase inhibitor in pleural fluid for the diagnosis of benign asbestos pleural effusion. Sci Rep.
Chicago Style CitationKishimoto, Takumi, Yoko Kojima, and Nobukazu Fujimoto. "Significance of Secretory Leukocyte Peptidase Inhibitor in Pleural Fluid for the Diagnosis of Benign Asbestos Pleural Effusion." Sci Rep 2021.
MLA CitationKishimoto, Takumi, Yoko Kojima, and Nobukazu Fujimoto. "Significance of Secretory Leukocyte Peptidase Inhibitor in Pleural Fluid for the Diagnosis of Benign Asbestos Pleural Effusion." Sci Rep 2021.
Warning: These citations may not always be 100% accurate.